• The Susan F. Smith Center for Women's Cancers at Dana-Farber unites many of the world's leading experts in breast and gynecologic cancers with one common goal: to give all women the latest, most advanced care, including innovative therapies that are often available only through clinical trials.

    A place of hope and action, the Susan F. Smith Center for Women's Cancers offers multi-dimensional services to strengthen mind, body, and soul and to help alleviate mental and emotional burdens. Ending women's cancers are the reason we exist. Everything we do – from the moment a patient pulls into the parking lot until the moment they leave the building after their last treatment – is tailored to the unique needs of women.

  • Our physicians are deeply committed to providing expert, compassionate care and to conducting active research to benefit current patients and future generations of women.

    Susan F. Smith Center for Women's Cancers

    FPO

    Dr. Dirk Iglehart received his MD from Harvard Medical School in 1975. After serving as a surgical intern, research fellow, and house staff officer at Duke University Medical Center between 1975 and 1984, he was appointed to the Duke faculty and subsequently promoted to professor of surgery. In 1999, he joined Dana-Farber, where he is director of the Susan F. Smith Center for Women's Cancers. His research focuses on the molecular biology of breast cancer and the early steps in cancer invasion and progression. He is also the Charles A. Dana Senior Investigator in Cancer Genetics at Dana-Farber, the chief of the Cancer Biology Section in the Department of Surgery at Brigham and Women's Hospital, and the Anne E. Dyson Professor in Women's Cancer and Surgery at Harvard Medical School. He is the principal investigator of the NCI-funded Specialized Program of Research (SPORE) in breast cancer at Harvard.
    Additional Biographical Information 

    Breast Oncology Program

    FPO

    Dr. Eric Winer received his MD from Yale University in 1983, and later completed training in internal medicine and served as chief resident at Yale-New Haven Hospital. He subsequently was a fellow in hematology-oncology at Duke University Medical Center. From 1989 to 1997, Dr. Winer served on the Duke faculty, where he became co-director of the multidisciplinary breast program. In 1997, he joined Dana-Farber/Brigham and Women’s Cancer Center, where he serves as director of the Susan F. Smith Center for Women's Cancers Breast Oncology Program. Dr. Winer is also the chief of the Division of Women's Cancers at Dana-Farber and the Thompson Senior Investigator in Breast Cancer Research. He is a Professor of Medicine at Harvard Medical School.
    Additional Biographical Information
    Full Treatment Team 

    Gynecologic Oncology Program

    FPO

    Dr. Ursula A. Matulonis is medical director of the Gynecologic Oncology Program at the Susan F. Smith Center for Women's Cancers and Associate Professor of Medicine at Harvard Medical School. Her research focuses on targeted therapies for gynecologic malignancies, with a specific interest in the genetic changes in ovarian cancer and how that can lead to rationale targeted drug selection. Dr. Matulonis is the Principal Investigator of several clinical trials and translational studies for ovarian cancer.
    Additional Biographical Information
    Full Treatment Team 

    Center for Cancer Genetics and Prevention

    FPO

    Dr. Judy Garber is the director of the Center for Cancer Genetics and Prevention. She received her MD and MPH in 1981 from Yale University School of Medicine. She served her internal medicine residency at Brigham and Women's Hospital (BWH), followed by fellowships in hematology at BWH, medical oncology at Dana-Farber, and biostatistics at the National Cancer Institute. She joined Dana-Farber as a fellow in 1985, and now works as a medical oncologist and clinical cancer geneticist. Dr. Garber is a Professor of Medicine at Harvard Medical School.
    Additional Biographical Information
    Full Treatment Team